Company page
Bright Minds Biosciences Inc.
Bright Minds Biosciences Inc. is a public company trading under the ticker DRUG on the Canadian market. The company has a market capitalization of approximately CAD 593.7 million. Bright Minds focuses on developing innovative treatments in the field of neuroscience.
- Ticker
- DRUG:CSE
- Asset type
- Stock
- Market cap
- $593.7M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- CSE
- Currency
- CAD